Search

Author/Creator Lopez, P. Font

1. SF3B1 Mutation in Low-Risk MDS: Impact of its Incorporation to the Updated 2016 Who Classification and Relationship with Ferric Overload. (April 2017)

Authors:
Velao, S. Redondo; Laperche, C. Martinez; Suarez, J.; Chicano, M.; Ferrnandez, N.; Carbonell, D.; Buno, I.; Diez-martin, J.L.; Lopez, P. Font
Journal:
Leukemia research
Issue:
Volume 55(2017)Supplement 1
Page Start:
S111
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: RANDOMIZED PHASE 2 STUDY TO ASSESS SAFETY AND EFFICACY OF LOW-DOSE (LD) ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS: INTERIM SAFETY ANALYSIS. (May 2023)

Authors:
Garcia-Manero, G.; Bachiashvili, K.; Griffiths, E.; Traer, E.; Saini, L.; Amin, H.; Zeidan, A.; Mohan, S.; Lübbert, M.; Maness, L.; Foran, J.; Selleslag, D.; Xicoy, B.; Pollyea, D.; Sallman, D.; Al-Kali, A.; Berdeja, J.; Al-Ali, H.; Zhu, N.; Lopez, P. Font
Journal:
Leukemia research
Issue:
Volume 128(2023)Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search